Development and evaluation of dual controlled release microballoons containing riboflavin and citric acid: in vitro and in vivo evaluation

References

• Akimoto M, Sato Y, Nemoto E, Todo H, Hasegawa T, Suugibayashi K. Pharmacokinetic profile of flavin adenine dinucleotide, flavin mononucleotide and riboflavin following intravenous administration of riboflavin or its coenzymes in rats. J Health Sci 2007; 53(3)332–8
   Google Scholar
• Aulton ME. Pharmaceutics – the science of dosage form design, 2nd. Churchill Livingstone, London 2002; 207–8
   Google Scholar
• Bajpai SK, Dubey S. Dynamic release of vitamin B2 from floating barium alginate beads for gastric delivery. J Macromol Sci, Part A: Pure Appl Chem 2008; 44: 1005–11
   Web of Science ®Google Scholar
• Bolton S. Pharmaceutical statistics: Practical and clinical applications. Marcel Dekker, New York 1997
   Google Scholar
• Davis SS. Formulation strategies for absorption windows. Drug Discovery Today 2005; 10(4)249–57
   PubMed Web of Science ®Google Scholar
• Dominguez-Munoz JE, Leodolter A, Sauerbruch T, Malfartheriner P. A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997; 40: 459–62
   PubMed Web of Science ®Google Scholar
• Dressman JB, Lennernas H. Oral drug absorption: Prediction and assessment. Marcel Dekker, New York 2000; 106: 155–79
   Google Scholar
• El-Kamel AH, Sokar MS, Al gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm 2001; 220: 13–21
   PubMed Web of Science ®Google Scholar
• Fox PF, McSweeney PLH. Vitamin in milks and dairy products. In: Dairy chemistry and biochemistry, 1st. Blackie Academic & Professional, Madras 1998; 265–93
   Google Scholar
• Gohel MC, Mehta PR, Dave RK, Bariya NH. A more relevant dissolution method for evaluation of floating drug delivery system. Disso Tech 2004; 11(4)22–5
   Google Scholar
• Graham DY, Runke D, Anderson SY, Malaty HM, Klein PD. Critic acid as the test meal for the 13C-urea breath test. Am J Gastroenterol 1999; 94: 1214–17
   PubMed Web of Science ®Google Scholar
• Groning R, Berntgen M. Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule. Pharmazie 1996; 51: 328–31
   PubMed Web of Science ®Google Scholar
• Groning R, Werner M, Berntgen M, Geogorakis M. Peroral controlled release dosage forms with internal magnets and extracorporal magnetic guidance – investigations into the renal elimination of riboflavin. Eur J Pharm Biopharm 1996; 42: 25–8
   Web of Science ®Google Scholar
• Hamdani J, Goole J, Moes AJ, Amighi K. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. Int J Pharm 2006; 323: 86–92
   PubMed Web of Science ®Google Scholar
• Hunt JN, Knox MT. The regulation of gastric emptying of meals containing citric acid and salts of citric acid. J Physiol 1962; 163: 34–45
   PubMed Web of Science ®Google Scholar
• Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm 1998a; 174: 47–54
   Web of Science ®Google Scholar
• Iannuccelli V, Coppi G, Leo E, Fontana F, Bernabei MT. PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. Drug Dev Ind Pharm 2000; 26: 595–603
   PubMed Web of Science ®Google Scholar
• Iannuccelli V, Coppi G, Sansone R, Ferolla G. Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. Int J Pharm 1998b; 174: 55–62
   Web of Science ®Google Scholar
• Ingani HM, Timmermans J, Moes AJ. Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. Int J Pharm 1987; 35: 157–64
   Web of Science ®Google Scholar
• Kagan L, Lapidot N, Afargan M, Kirmayer D, Moor E, Mardor Y, Friedman M, Hoffman A. Gastroretentive accordion pill: Enhancement of riboflavin bioavailability in humans. J Controlled Release 2006; 113: 208–15
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992; 81: 135–40
   PubMed Web of Science ®Google Scholar
• Krishna RR, Siraj P, Sastry CSP. Spectrophotometric determination of citric acid with metol and chromium (VI). Fresenius J Anal Chem 1980; 303(5)411
   Google Scholar
• Martin A, Bustamante P, Chun A. Micromeritics. In: Physical pharmacy-physical chemical principles in the pharmaceutical sciences, 4th. Lippincott Williams and Wilkins, Baltimore 2002; 446–8
   Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients, 5th. Pharmaceutical Press, London 2006; 185–7
   Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. The physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2003a; 55: 297–304
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers. J Controlled Release 2003b; 93: 39–47
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int J Pharm 2004a; 275: 97–107
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H, Fujibayashi Y. Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. J Controlled Release 2004b; 98: 75–85
   PubMed Web of Science ®Google Scholar
• Shoaib MH, Tanzeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci 2006; 19(2)119–24
   PubMedGoogle Scholar
• Stops F, Fell JT, Collett JH, Martini LG, Sharma HL, Smith AM. The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state. Int J Pharm 2006a; 308: 8–13
   PubMed Web of Science ®Google Scholar
• Stops F, Fell JT, Collett JH, Martini LG, Sharma HL, Smith AM. Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state. Int J Pharm 2006b; 308: 14–24
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Zahrooni M. Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsulation 2007; 24(3)253–62
   PubMed Web of Science ®Google Scholar
• Yao H, Xu L, Han F, Che X, Dong Y, Wei M, Guan J, Shi X, Li S. A novel riboflavin gastro-mucoadhesive delivery system based on ion-exchange fiber. Int J Pharm 2008; 364(1)21–6
   PubMed Web of Science ®Google Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res 2004; 27(1)1–12
   PubMed Web of Science ®Google Scholar